<DOC>
	<DOCNO>NCT02100956</DOCNO>
	<brief_summary>The purpose study determine effect oxytocin give spinal fluid pain area intensity hyperalgesia allodynia patient chronic neuropathic pain .</brief_summary>
	<brief_title>Efficacy Intrathecal Oxytocin Patients With Neuropathic Pain</brief_title>
	<detailed_description>Rationale : The investigator anticipate oxytocin effective spinal injection human acutely relieve chronic neuropathic pain . Objectives : Determine effect intrathecal oxytocin pain area intensity hyperalgesia allodynia patient chronic neuropathic pain . Interventions : A computer generate randomization use determine group subject . Subjects randomize receive intrathecal injection saline ( placebo ) oxytocin .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Weight &lt; equal 240 pound Neuropathic pain &gt; 6 month : primary pain area umbilicus Hypersensitivity , allergy , significant reaction ingredient study drug lidocaine Any disease , diagnosis , condition ( medical surgical ) , opinion Principal Investigator , would place subject increase risk ( active gynecologic disease increase tone would detrimental e.g. , uterine fibroid ongoing bleeding ) , compromise subject 's compliance study procedure , compromise quality data Pregnancy spinal cord stimulators , chronic intrathecal drug therapy , oral opioid treatment &gt; 3 month current dose &gt; 100 milligram ( mg ) morphine per day equivalent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>chronic pain</keyword>
	<keyword>neuropathic pain</keyword>
</DOC>